After a string of breaches involving anthrax, Ebola, and bird flu, the US Centers for Disease Control and Prevention has reportedly replaced the director of its Division of Select Agents and Toxins.

Two studies point to the possibility that a single vaccine could protect against every strain of flu virus.

In the wake of a handful of biosafety lapses at federal research facilities, the US government is temporarily halting funding for new studies aiming to give novel functions to influenza, SARS, and MERS viruses.

The US government releases its policy on so-called dual-use research involving dangerous pathogens that could be used for biological terrorist attacks.

The Centers for Disease Control and Prevention scientist who accidentally leaked H5N1 into a benign strain of avian influenza may have been rushing off to a meeting.

A person in Canada has died of the first confirmed human case of H5N1 avian flu in North America.

A group of scientists has called on the European Commission to evaluate the risks and benefits of research that could make deadly viruses more transmissible.

The US Food and Drug Administration OKs a vaccine against the virus that last year had the scientific community debating the regulation of deadly pathogen research.

The Dutch scientist who mutated a strain of the avian flu virus to be transmissible between mammals is headed to appeals court to protect his right to publish the work unimpeded.

Researchers develop a new “molecular biocontainment” strategy for safely studying deadly flu viruses.